1
|
Hopfer H, Rinehart CA, Kaufman DG and
Vollmer G: Basement membrane induced differentiation of HEC-1B(L)
endometrial adenocarcinoma cells affect both morphology and gene
expression. Biochem Cell Biol. 74:165–177. 1996. View Article : Google Scholar
|
2
|
Kubushiro K, Kojima K, Mikami M, Nozawa S,
Iizuka R, Iwamori M and Nagai Y: Menstrual cycle-associated
alteration of sulfogalactosylceramide in human uterine endometrium.
Arch Biochem Biophys. 268:129–136. 1989. View Article : Google Scholar : PubMed/NCBI
|
3
|
Kiguchi K, Takamastu K, Tanaka J, Nozawa
S, Iwamori M and Nagai Y: Glycosphingoplipids of various human
ovarian tumors: a significantly high expression of
I3SO3 GalCer and Lewis antigen in mucinous
cyst adenocarcinoma. Cancer Res. 52:416–421. 1992.PubMed/NCBI
|
4
|
Kubushiro K, Tsukazaki K, Tanaka J,
Takamastu K, Kuguchi K, Mikami M, Nozawa S, Nagai Y and Iwamori M:
Human uterine endometrial adenocarcinoma: characteristic
acquirement of synthetic potentials for
II3SO3-LacCer and Ganglio series
sulfoglycosphingolipids after transfer of the cancer cells to
culture. Cancer Res. 52:803–809. 1992.
|
5
|
Nozawa S, Sakayori M, Ohta K, Iizuka R,
Mochizuki H, Soma M, Fujimoto J, Hata J, Iwamori M and Nagai Y: A
monoclonal antibody (MSN-1) against a newly established uterine
endometrial cancer cell lines (SNG-II) and its application to
immunohistochemıstry and flow cytometry. Am J Obstet Gynecol.
161:1079–1086. 1989.PubMed/NCBI
|
6
|
Ishiwata I, Nozawa S, Inoue T and Okumura
H: Development and characterization of established cell lines from
primary and metastatic region of human endometrial adenocarcinoma.
Cancer Res. 37:1777–1785. 1977.PubMed/NCBI
|
7
|
Nishida M, Kasahara K, Kaneko K, Iwasaki H
and Hayashi K: Establishment of a new human endometrial
adenocarcinoma cell line, Ishikawa cells, containing estrogen and
progesterone receptors. Acta Obstet Gynecol Jpn. 37:1103–1111.
1985.
|
8
|
Morizawa T: Establishment and
characterization of a endometrial cancer cell line. J Jpn Soc Clin
Cytol. 26:433–442. 1987. View Article : Google Scholar
|
9
|
Shimizu H, Inoue M and Tanizawa O:
Adoptive cellular immunotherapy to the endometrial cancer cell line
xenografts in nude mice. Gynecol Oncol. 34:195–199. 1989.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Behrens P, Meissner C, Hopfer H, Schümann
J, Tan MI, Ellerbrake N, Strunck E and Vollmer G: Laminin mediates
basement membrane induced differrentiation of HEC 1B endometrial
adenocarcinoma cells. Biochem Cell Biol. 74:875–886. 1996.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Taraboletti G, Rao CN, Krutzsch HC, Liotta
LA and Roberts DD: Sulfatide-binding domain of the laminin A chain.
J Biol Chem. 265:12253–12258. 1990.PubMed/NCBI
|
12
|
Kawakita M, Tsuji Y, Nakata Y, Ogasawara
T, Takemura T, Isojima S and Koyama K: Progesterone treatment
decreases sulfate carbohydrate antigen on endometrial carcinoma
cells and inhibits the cell binding to laminin. Gynecol Oncol.
57:313–320. 1995. View Article : Google Scholar
|
13
|
Kuroki T, Ikuta T, Kashiwagi M, Kawabe S,
Ohba M, Huh N, Mizuno K, Ohno S, Yamada E and Chida K: Cholesterol
sulfate, an activator of protein kinase C mediating squamous cell
differentiation: a review. Mutat Res. 462:189–195. 2000. View Article : Google Scholar : PubMed/NCBI
|
14
|
Kashiwagi M, Ohba M, Chida K and Kuroki T:
Protein kinase C eta (PKC eta): its involvement in keratinocyte
differentiation. J Biochem. 132:853–857. 2002. View Article : Google Scholar : PubMed/NCBI
|